|Articles|April 1, 2004
Infliximab effectively treats psoriasis
Washington, D.C. - Infliximab treatment of plaque psoriasis is equally effective regardless of patient gender, body mass index, extent of psoriasis involvement, history of other systemic psoriasis therapy, or whether there is concomitant psoriatic arthritis, according to results of two studies presented here during the 62nd annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
3
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
4
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
5














